← Evidence map

ArticleFrontiers in neurology2025

CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany.

Mathias Buttmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40470489